🇺🇸 FDA
Patent

US 9475795

Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases

granted A61KA61K31/454A61K31/4545

Quick answer

US patent 9475795 (Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases) held by Takeda Pharmaceutical Company Limited expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
47
CPC classes
A61K, A61K31/454, A61K31/4545, A61K45/06, A61P